期刊
RADIOTHERAPY AND ONCOLOGY
卷 88, 期 2, 页码 217-226出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2007.10.026
关键词
brachytherapy; cervix; optimisation; MRI
Background and purpose: In this study on PDR treatment planning of utero-vaginal carcinoma, we analysed the dosimetry of traditional X-ray based plans as it presents on MR images. The potential gain of MRI-based dose optimisation was assessed. Patients and methods: Sixteen patients boosted with PDR brachytherapy after external beam therapy were included. The clinical X-ray based plans were projected on MR images. The GTV, HR-CTV and IR-CTV were retrospectively contoured, as well as the bladder, rectum and sigmoid colon. The dose in the critical organs and target coverage was investigated. In a second phase, the plans were manually optimised using the MR information. The objectives were to lower the dose in the critical organs (<= 85 Gy(alpha beta 3) for bladder, <= 75 Gy(alpha beta 3) for rectum and sigmoid colon) and to increase the HR-CTV dose to D90 >= 85 Gy(alpha beta 10). Results: In the X-ray based plans, D-2cc in bladder and sigmoid colon exceeded the tolerance doses in 10/16 and 7/16 patients, respectively. Coverage of the IR-CTV with the 60 Gy(alpha beta 10) was acceptable. D90 of the HR-CTV was below 85 Gy(alpha beta 10) in 13 out of 16 patients. After optimisation, the dose constraints in the OAR were not exceeded anymore in any patient. The average D-2cc dose reduction was 7 +/- 6 Gy(alpha beta 3) in the bladder and 7 +/- 4 Gy(alpha beta 3) in the sigmoid colon for those patients in which the dose constraint was initially exceeded. In addition, an average dose increase of 3 Gy(alpha beta 10) was accomplished in the HR-CTV. Conclusions: MRI-based dose optimisation can play an important role to reduce the dose delivered to the critical organs and to improve target coverage. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据